Top Executive Makes Bold Insider Move at Aprea Therapeutics
at www.tipranks.com (Mon, 2-Feb 9:01 PM)
Aprea’s WEE1 Inhibitor APR-1051 Shows Early Promise: Partial Response Observed in Endometrial Cancer Trial
Market Chameleon (Fri, 30-Jan 11:06 AM)
